AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue7,5792,51519,024
Cost of Revenue---
Gross Profit7,5792,51519,024
Operating Expenses
Research Development25,17923,70312,875
Selling General and Administrative9,1388,20510,217
Non Recurring2,0732,0738,358
Total Operating Expenses---
Operating Income or Loss-28,811-29,393-12,426
Income from Continuing Operations
Total Other Income/Expenses Net-33,7404,556-289
Earnings Before Interest and Taxes-62,551-24,837-12,715
Interest Expense2,3731,9492,286
Income Before Tax-64,924-26,786-15,001
Income Tax Expense101101-
Minority Interest---
Net Income From Continuing Ops-65,025-26,887-15,001
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-65,025-26,887-15,001
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-65,025-26,887-15,001